Biotech News

P3 Health Partners to Participate in the Jefferies Healthcare Services Conference

P3 Health Partners (PIII)P3 Health Partners2025-09-17 20:05 ESTConference / presentation

PIII (PIII) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is piii.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

PIIIP3 Health Partners2026-07-21 20:05 EST

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

PIIIP3 Health Partners2026-05-14 20:05 EST

P3 Health Partners Announces First Quarter 2026 Results

PIIIP3 Health Partners2026-04-16 20:05 EST

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

PIIIP3 Health Partners2026-03-26 20:05 EST

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

PIIIP3 Health Partners2026-03-13 12:05 EST

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

PIIIP3 Health Partners2025-12-02 21:05 EST

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

PIIIP3 Health Partners2025-11-24 21:05 EST

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

PIIIP3 Health Partners2025-11-13 22:30 EST

P3 Health Partners Announces Third Quarter 2025 Results

PIIIP3 Health Partners2025-10-21 20:05 EST

P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

PIIIP3 Health Partners2025-08-14 20:05 EST

P3 Health Partners Announces Second Quarter 2025 Results

View all latest news

P3 Health Partners

P3 Health Partners is a physician-led healthcare services company focused on senior-care value-based management. Its business is about care coordination and Medicare-oriented economics rather than biotech.

Recent company news

PIIIBruker2026-07-24 20:01 EST

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

PIIIQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

PIIIMolina Healthcare2026-07-22 20:15 EST

Molina Healthcare Reports Second Quarter 2026 Financial Results

PIIIAxon Enterprise, Inc.2026-07-22 20:01 EST

Axon to Release Second Quarter 2026 Earnings on August 5, 2026

PIIIGSK plc2026-07-22 11:21 EST

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Stock data

Close: 9.31 USD
Market cap: 42.54M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States